Headache & Pain

Filter Your Results

 

News

 

Atogepant Demonstrates Efficacy and Safety for Prevention of Episodic Migraine

Wednesday, June 13, 2018—In a phase 2b/3 clinical trial (CGP-MD-01) of the orally administered calcitonin gene-related peptide receptor (CGRP) antagonist, atogepant (Allergan, Ireland), all primary en…

We Are All Headache Specialists

Peter McAllister, MD

June 2018—Erenumab approval heralds a new era in headache medicine.

BrainStorm to Host Phone Discussion of Right to Try Legislation and Stem Cell Therapy June 7th

Friday, June 01, 2018—Brainstorm Cell Therapeutics Inc (New York, NY) will host a phone call on June 7th at 8:15 AM EDT to provide interested parties an opportunity to engage with the company regar…

Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Pain

Wednesday, May 23, 2018—Topline results the first pivotal phase 3 clinical trial of intravenous (IV) tramadol (Avenue Therapeutics, New York, NY) have been released. Enrolled patients were randomized…

New Type of Vertigo Defined That May Be Treatable

Wednesday, May 23, 2018—Neurologists have defined a new type of vertigo with no known cause (Neurology. 2018:published online May 23). The authors have differentiated this type of vertigo from seriou…

First Monoclonal Antibody Blocking CGRP Approved for Treatment of Migraine

Friday, May 18, 2018—The Food and Drug Administration today approved erenumab-aooe (Aimovig; Novartis, East Hanover, NJ) for prevention of migraine in adults. Erenumab is a monoclonal antibody tha…

OnabotulinumtoxinA for Migraine Has Long-Term Safety and Efficacy

Friday, May 04, 2018—A wealth of results showing the long-term safety and efficacy of onabotulinumtoxinA (Botox; Allergan, Dublin, Ireland) for treating patients with migraine were presented at th…

Noninvasive, Cost-Effective Neuromodulation Therapy for Migraine and Cluster Headache

Wednesday, May 02, 2018—At the recent American Academy of Neurology meeting in Los Angeles, CA, electroCore, a commercial-stage bioelectronic medicine company, presented data from the PRESTO study of…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC